The global cranial implants market size is anticipated to reach USD 2.09 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 6.5% from 2025 to 2030. Increasing cases of Traumatic Brain Injury (TBI) and brain tumors are anticipated to boost the market.
The cranial implants market is experiencing a shift toward advanced materials that offer enhanced biocompatibility and functionality. While polymers and metals remain the primary materials, ceramic implants are gaining traction due to their favorable aesthetic outcomes and similarity to natural bone.
Technological advancements, including 3D printing, Computer-aided Design and Manufacturing (CAD/CAM) for implant creation, and tissue engineering therapies aimed at regenerating larger bone defects, are significant drivers of market expansion. For instance, in April 2024, 3D Systems received Food and Drug Administration (FDA) 510(k) clearance for its patient-specific VSP PEEK Cranial Implant, which is manufactured using 3D printing technology. This regulatory clearance highlights the growing adoption of 3D printing in standard clinical practice and its potential to significantly transform cranial reconstruction procedures.
Request a free sample copy or view report summary: Cranial Implants Market Report
By product, the customized segment held the largest revenue share approximately about 87% in 2024, attributed to the increasing number of patients suffering from brain defects due to brain tumors and TBIs
By material, polymer segment held a major market share in 2024, owing to increasing usage of polymer in cranioplasty surgical procedure for treatment of skull defects and brain tumor
Hospitals led the cranial implants market with a revenue share in 2024 due to the availability of skilled neurosurgeons and improving healthcare infrastructure in developing countries
North America dominated the global market with a major share in 2024, owing to the adoption of technologically advanced products, government initiatives, and high disposable income
Key players opt for technologically enhanced products to gain a competitive edge. In August 2024, Longeviti Neuro Solutions, a neurotechnology company headquartered in Maryland, was granted a U.S. patent for its innovative translucent prosthetic cranial implant designed for application in neurosurgical procedures.
For the purpose of this report, Grand View Research has segmented the cranial implants market on the basis of product, material, end use, and region:
Cranial Implants Product Outlook (Revenue, USD Million, 2018 - 2030)
Customized
Non-customized
Cranial Implants Material Outlook (Revenue, USD Million, 2018 - 2030)
Polymer
Ceramic
Metal
Cranial Implants End Use Outlook (Revenue, USD Million, 2018 - 2030)
Hospital
Neurosurgery Centers
Cranial Implants Region Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
U.K.
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
South Korea
Thailand
Latin America
Brazil
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players in the Cranial Implants Market
B. Braun SE
Johnson & Johnson Services, Inc.
Stryker
Zimmer Biomet
Acumed LLC
evonos GmbH & Co. KG
Medartis AG
Renishaw plc.
Kelyniam Global Inc.
Anatomics Pty Ltd
"The quality of research they have done for us has been excellent..."